VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Prof. Zhu Tao: QLS5132 First-in-Human Study Shows Efficacy & Safety Breakthrough for Platinum-Resistant Ovarian Cancer
Prof. Zhu Tao: QLS5132 First-in-Human Study Shows Efficacy & Safety Breakthrough for Platinum-Resistant Ovarian Cancer
May 19, 2026 18:11 CST Updated 18:29
Share:
